Frank Rimerman Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,294
Closed -$219K – 612
2026
Q2
$219K Sell
2,294
-763
-25% -$73.2K 0.01% 581
2026
Q1
$317K Buy
+3,057
New +$347K 0.02% 483
2025
Q4
– Sell
-2,500
Closed -$308K – 608
2025
Q3
$308K Buy
+2,500
New +$310K 0.02% 481
2025
Q2
– Sell
-1,571
Closed -$231K – 569
2025
Q1
$231K Buy
1,571
+150
+11% +$22.9K 0.02% 469
2024
Q4
$231K Buy
1,421
+156
+12% +$25.5K 0.02% 469
2024
Q3
$206K Buy
+1,265
New +$187K 0.01% 507

Other funds holding CLX

Frank Rimerman Advisors's CLX Position: Q3 2026 in Review

Frank Rimerman Advisors sold out of Clorox (CLX) in Q3 2026, closing a stake of 2,294 shares — an estimated $219K sold.

Frank Rimerman Advisors first reported a position in CLX in Q3 2024 and held it in 6 quarters. The position peaked at $317K in Q1 2026. 634 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • Frank Rimerman Advisors reported no remaining Clorox position as of Q3 2026 after selling out during the quarter.
  • Frank Rimerman Advisors sold 2,294 Clorox shares in Q3 2026, an estimated $219K.
  • Frank Rimerman Advisors first reported a position in Clorox in Q3 2024 and held it in 6 quarters.
  • Frank Rimerman Advisors's Clorox position peaked at $317K in Q1 2026.
  • 634 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.